Featured Stories

Boston Scientific’s commitment to improving the lives of patients extends to to protecting the planet we all share. Reducing our carbon footprint is a cornerstone of our efforts to confront climate change...

With more than 1.2 million people affected in Europe alone, Parkinson’s Disease (PD) is a major movement disorder. April is Parkinson’s Awareness month and people worldwide are raising awareness about the condition and stories from the community.

A new Institute for Advancing Science (IAS) has opened in the UK where health care professionals (HCPs) are receiving expert training on medical technologies from Boston Scientific to improve...

MILANO, 3 febbraio 2025 – Alessandro Albano è stato nominato nuovo Country Leader di Boston Scientific in Italia e guiderà l’azienda nei prossimi tre anni, identificando e implementando le...

Boston Scientific announces the appointment of Faruk Uzman as the new vice president for Healthcare Solutions & Partnerships (HS&P) and Remote Sales for Europe, Middle East, and Africa (EMEA),...

Boston Scientific announces the appointment of Kathleen Van Vlierberghe as the new vice president for the Peripheral Interventions division in Europe, Middle East and Africa (EMEA), effective 1...

For Tony McDonough, a resident of the U.K. and a person with Type 1 diabetes, peripheral artery disease (PAD) was more than just a medical condition - it was a life-altering challenge.

The kidneys are a symmetrical pair of bean-shaped organs positioned on either side of the spine, situated just beneath the ribcage. Each kidney functions as a highly efficient filtration system...

Boston Scientific announces new leader for Europe, Middle East, and Africa

Atrial fibrillation (AF) is a common heart rhythm disorder affecting millions of people worldwide. In Europe alone, over 6 million individuals live with this condition. AF can significantly...